PitchBook-2025年三季度卫生技术公共报表和评估指南（英）-2025

2025-11管理咨询8免费

📄 文件全名: 《PitchBook-2025年三季度卫生技术公共报表和评估指南（英）-2025-8页.pdf》
🎯 适合读者: 战略规划行业研究员
📊 核心数据: performance in the EHRs & clinical information segment has been particularly weak, with share prices down 11% on average so far
in 2025. The virtual care & RPM segment has also seen negative returns on average, down 3% YTD. However, recent listings by
underperformance trend this year include iRhythm Technologies, up 92%, Doximity, up 37%, and Sectra, up 30%.
• Claritev surges over 300%: After beating Q2 revenue expectations, Claritev’s stock soared, ending Q3 up 310% on the year and
nearly 30% when Novo Nordisk abruptly called off the deal. Yet investor optimism has returned—shares are up 125% YTD and
🏷️ 核心议题: #管理咨询

📦 本报告属于月份合集

购买后将获得「2025 年 11 月报告合集」 · 共 4338 份报告打包下载链接

点击获取云盘下载链接

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

📋 核心要点(部分)

1 week
30 days
90 days

❓ 常见问题

《PitchBook-2025年三季度卫生技术公共报表和评估指南（英）-2025》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:performance in the EHRs & clinical information segment has been particularly weak, with share prices down 11% on average so far;in 2025. The virtual care & RPM segment has also seen negative returns on average, down 3% YTD. However, recent listings by;underperformance trend this year include iRhythm Technologies, up 92%, Doximity, up 37%, and Sectra, up 30%.。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 8。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合战略规划、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了管理咨询等议题。